Skyeline Management Ltd
SEC CIK 1814877 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | 10% | 7.88M | — | $16.00M | 2 | 2022-08-25 | 2022-12-01 |
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Skyeline Management Ltd made no open-market trades at RPRX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-05 | 2022-12-01+ | RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% | S - Sale | $44.04 | -362.8K | 7.88M | -4% | -$15.98M |
| I | 2022-08-29 | 2022-08-25 | RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% | S - Sale | $44.00 | -500 | 9.08M | -0.0% | -$22.0K |
Purchase Sale Sale after option exercise All abbreviations